Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives

Inflammatory bowel disease (IBD) is an idiopathic chronic inflammatory disease of the gastrointestinal system. The spectrum is of predominantly two types, namely, ulcerative colitis and Crohn’s disease. The incidence of IBD has been increasing steadily since 1990, and so the number of agents used in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawla, Prashanth, Sunkara, Tagore, Raj, Jeffrey Pradeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961645/
https://www.ncbi.nlm.nih.gov/pubmed/29844695
http://dx.doi.org/10.2147/JIR.S165330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961645/
https://www.ncbi.nlm.nih.gov/pubmed/29844695
http://dx.doi.org/10.2147/JIR.S165330

Ejemplares similares